Join
Live feed
·
INSIDERFilingvia Quantisnow
Rhythm Pharmaceuticals Inc. logo

Chief Technical Officer Shulman Joseph exercised 2,024 shares at a strike of $6.80 and sold $608,210 worth of shares (5,079 units at $119.75) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 15,915 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RYTM (Rhythm Pharmaceuticals Inc.) and more on Quantisnow.